Table 3 Long COVID symptoms in 113 COVID-19-vaccinated patients stratified by number of vaccination doses.
Long COVID symptoms | < 3 vaccination doses | ≥ 3 vaccination doses | Total | P value |
|---|---|---|---|---|
(N = 36) | (N = 77) | (N = 113) | ||
Fatigue | 1.000 | |||
 Yes | 9 (25.0%) | 20 (26.0%) | 29 (25.7%) |  |
 No | 27 (75.0%) | 57 (74.0%) | 84 (74.3%) |  |
Amnesia | 0.786 | |||
 Yes | 10 (27.8%) | 18 (23.4%) | 28 (24.8%) |  |
 No | 26 (72.2%) | 59 (76.6%) | 85 (75.2%) |  |
Insomnia | 0.678 | |||
 Yes | 6 (16.7%) | 17 (22.1%) | 23 (20.4%) |  |
 No | 30 (83.3%) | 60 (77.9%) | 90 (79.6%) |  |
Difficulty concentrating | 0.276 | |||
 Yes | 10 (27.8%) | 13 (16.9%) | 23 (20.4%) |  |
 No | 26 (72.2%) | 64 (83.1%) | 90 (79.6%) |  |
Depression | 1.000 | |||
 Yes | 6 (16.7%) | 12 (15.6%) | 18 (15.9%) |  |
 No | 30 (83.3%) | 65 (84.4%) | 95 (84.1%) |  |
Anxiety | 1.000 | |||
 Yes | 6 (16.7%) | 13 (16.9%) | 19 (16.8%) |  |
 No | 30 (83.3%) | 64 (83.1%) | 94 (83.2%) |  |
Cognitive dysfunction | 1.000 | |||
 Yes | 2 (5.6%) | 4 (5.2%) | 6 (5.3%) |  |
 No | 34 (94.4%) | 73 (94.8%) | 107 (94.7%) |  |
Anosmia | 0.541 | |||
 Yes | 1 (2.8%) | 6 (7.8%) | 7 (6.2%) |  |
 No | 35 (97.2%) | 71 (92.2%) | 106 (93.8%) |  |
Ageusia | 1.000 | |||
 Yes | 0 (0.0%) | 1 (1.3%) | 1 (0.9%) |  |
 No | 36 (100.0%) | 76 (98.7%) | 112 (99.1%) |  |
